SLC5A2 and type 2 diabetes mellitus: However, concerns about the safety and efficacy of SGLT2 inhibitors during prolonged Ramadan fasting prompted this clinical trial to assess the effectiveness of ertugliflozin in T2DM patients observing Ramadan in Bangladesh (32).